Skip to content

The effects of cipepofol and propofol on hemodynamics and cardiac function in patients undergoing debridement after coronary artery bypass

The effects of cipepofol and propofol on hemodynamics and cardiac function in patients undergoing debridement after coronary artery bypass

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129356
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-08-05
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep sternal wound infection

Interventions

Group C:Using cipepofol for anesthesia induction and maintenance
Group P:Using propofol for anesthesia induction and maintenance

Sponsors

Beijing Aerospace General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Voluntarily participate in this study and sign the informed consent form; (2) Patients who have undergone coronary artery bypass surgery within the past 6 months and are planning to undergo thoracoplasty; (3) American Society of Anesthesiologists (ASA) classification level II to III; (4) Left ventricular ejection fraction (LVEF) >= 45%; (5) Age 18 years or older and 75 years or younger; (6) BMI 18 to 30 kg/m2

Exclusion criteria

Exclusion criteria: (1) Have a history of allergy or contraindication to anesthetic drugs (including those in the excipients of propofol or etomidate injection: such as soybean oil, glycerin, egg yolk lecithin, etc.);(2) Have other important organ dysfunction (such as liver, kidney, respiratory, blood, nervous, immune or metabolic systems);(3) Need vasoactive drugs to maintain hemodynamic stability before the operation;(4) Have severe arrhythmia (such as second-degree or above atrioventricular conduction block, ventricular tachycardia, etc.);(5) Pregnant, lactating or planning to have a baby within the next six months;(6) Have long-term use of psychotropic drugs or glucocorticoids before the operation;(7) Have a severely difficult airway;(8) Have moderate to severe cognitive dysfunction;(9) Need to use diuretics for treatment before the operation;(10) Patients considered by the researchers to have any other factors that are not suitable for participating in this experiment

Design outcomes

Primary

MeasureTime frame
AUC;

Secondary

MeasureTime frame
Hemodynamic indicators;Dosage of vasoactive drugs;Quality of awakening;Cardiac injury markers;Adverse Reactions;

Countries

China

Contacts

Public ContactXiong Tian

Beijing Aerospace General Hospital

22346399@qq.com+86 138 1117 5393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026